Hide

‘Pharma Bro’ was on ‘war path’ after firm tried to force him out: CEO

The current CEO of Martin Shkreli’s drug company Retrophin testified Friday that the “Pharma Bro” went on a “war path” to hurt the company in retaliation to being forced out. Shkreli’s reign as CEO of the biopharmaceutical firm was chaotic – and included antics of out-of-control tweeting, inappropriately communicating with investors and even hiring a private eye to investigate employees without board members’ knowledge, his successor, Stephen Aselage, said in Brooklyn Federal Court. The board asked Shkreli to step down in September 2014 – but he refused. “He said I would regret my actions, that I’d never dealt with anyone like him before,” Aselage told jurors, calling his last conversation with Shkreli “host ...